1. Pink Sheet
  2. >>R&D
  3. >>Clinical Trials

Real-World Data Could Get Boost From Trial Replication Project

 
• By Derrick Gingery

Effort to replicate clinical trial results with real-world data could eventually allow for increased use in drug development.

Yellow road sign with a blue sky and white clouds: clinical trial

A project funded by the US FDA could lay the groundwork for potentially using real-world evidence instead of a clinical trial as part of a drug development strategy.

A group that includes Brigham and Women's Hospital, Harvard Medical School, and health care data company Aetion, is seeking to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

Belgium Slashes Clinical Trial Review Times In Push To Draw More Studies

 
• By Neena Brizmohun

Deadlines for reviewing applications for mononational trials in Belgium will be cut by 50%.

UK Regulator Expands Team To Assess Computer-Simulated Trials

 
• By Eliza Slawther

The UK MHRA is looking to support drug sponsors in using in silico data during the drug development process – a move that will reduce the use of animal models.

Brazil’s ‘Milestone’ Clinical Research Decree Expected To Double Clinical Trials

 
• By Francesca Bruce

A new decree in Brazil establishes a new ethics governance and operational structure in clinical research and seeks to better protect clinical trial participants.

ACCESS Consortium To Harmonize Clinical Trial Process Across Five Nations

 
• By Eliza Slawther

Clinical trial sponsors could soon benefit from a streamlined clinical trial approval process in Australia, Canada, Singapore, Switzerland and the UK under a new ACCESS Consortium project.

More from R&D

ACCESS Consortium To Harmonize Clinical Trial Process Across Five Nations

 
• By Eliza Slawther

Clinical trial sponsors could soon benefit from a streamlined clinical trial approval process in Australia, Canada, Singapore, Switzerland and the UK under a new ACCESS Consortium project.

Cancer Patient-Reported Outcomes Find Fertile Ground In GVHD, Myelofibrosis Labeling

 
• By Bridget Silverman

The FDA reviewed its efforts to bring PROs into cancer drug development at its 10th annual workshop on clinical outcome assessment in cancer trials.

Clinical Trials To Thrive Under New WHO Global Network

 
• By Anabel Costa-Ferreira

The World Health Organization’s Global Clinical Trials Forum brings optimism for pharma companies and other stakeholders, as it aims to strengthen the clinical trials environment and infrastructure across nations.